Thromboprophylaxis in spinal trauma surgery: consensus among spine trauma surgeons
To access this article, please choose from the options below
FDA device/drug status: not applicable.
Author disclosures: ARV (royalties: Depuy Spine, Biomet Spine, Globus, Medtronic, K2M, Aesculap; stock ownership: K2M, Cytonics, Disk Motion Technology, Zygoloc, Progressive Spinal Technology, Computational Dynamics, Stout Medical, Bonovo Orthopaedics, Electrocure, Vertiflex, Flagship Surgical, In vivo, Pearl Diver, Small Bone Innovations, Neucore, Crosscurrent, Vertilink, Orthovita, Syndicom, Biomerix, Spinemark, Paradigm Spine, Spinology, Vertebron, Replication Medica, Breakaway Imaging Cross Tree Medical, Globus; consulting: Depuy Spine, Osteotech, Othrofix, Vertiflex, Vertebron, Stryker Spine, K2M, Medtronic, AO Spine; research: AO Spine, Medtronic).
PII: S1529-9430(09)00048-5
doi:10.1016/j.spinee.2009.01.008
© 2009 Elsevier Inc. All rights reserved.
